Dive Brief: Short seller Kerrisdale Capital attacked atrial fibrillation-focused medtech AtriCure in a report Wednesday, arguing the company’s core cardiac ablation business is “structurally unprofitable” and its […]

AtriCure stock recovers after short seller predicts ‘complete collapse’ of business
Karam Dayoub
October 2, 2020